Aleksandra Bieniek, PharmD

Articles by Aleksandra Bieniek, PharmD

First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDA

ByAleksandra Bieniek, PharmD,Kevin Chamberlain, PharmD, FASCP

October 11th 2022

Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.

Latest Updated Articles

First-in-Class Treatment for Obstructive Hypertrophic Cardiomyopathy Is Approved by FDA
October 11th 2022

Trending on Drug Topics

PBM Underpayment Persists as Cost-Plus Brings New Strain | NCPA 2026

Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use

Q&A: Why Enforcement Is the Weak Link in State PBM Reform | NCPA 2026

FDA Approves Bepirovirsen Injection to Treat Chronic Hepatitis B

Vaccine Fatigue May Stall Patient Uptake More Than Hesitancy